Tudor Investment Corp’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Tudor Investment Corp’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-32,919	Closed	-$702K	–	2915
2024 Q1	$702K	Buy	+32,919	New	+$394K	﹤0.01%	1497
2020 Q3	–	Sell	-29,145	Closed	-$509K	–	1594
2020 Q2	$509K	Buy	+29,145	New	+$508K	0.03%	718

Tudor Investment Corp's FUSN Position: Q2 2024 in Review

Tudor Investment Corp sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 32,919 shares — an estimated $702K sold.

Tudor Investment Corp first reported a position in FUSN in Q2 2020 and held it in 2 quarters. The position peaked at $702K in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Tudor Investment Corp reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Tudor Investment Corp sold 32,919 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $702K.
Tudor Investment Corp first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q2 2020 and held it in 2 quarters.
Tudor Investment Corp's Fusion Pharmaceuticals Inc. Common Shares position peaked at $702K in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Tudor Investment Corp's 13F filing for Q2 2024, filed 14 Aug 2024.